| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0005 | 1 |